secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENZO BIOCHEM INC (—)
CIK:        0000316253
Form:       8-K
Filed at:   2025-08-20T23:59:59+00:00
Accession:  0001213900-25-078736
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 1.01, 3.01, 3.03, 5.03, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enzo Biochem completes merger with Bethpage Parent; stockholders to receive $0.70/share
--------------------------------------------------------------------------------

- Merger closed August 20, 2025; each share converted to $0.70 cash per the Merger Agreement.
- Shares ceased trading on OTCQX; company to file Form 15 to deregister and suspend SEC reporting.
- Directors Pully, Radoff, Couchman, and Cannon resigned at the effective time.
- Certificate of incorporation and bylaws were amended and restated in connection with the merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/316253/000121390025078736/0001213900-25-078736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/316253/000121390025078736/ea0253697-8k_enzo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-078736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer